# Treatment of Hypercholesterolaemia in Hispanic Subjects (STARSHIP)

> **NCT00653965** · PHASE3 · COMPLETED · sponsor: **AstraZeneca** · enrollment: 3000 (estimated)

## Conditions studied

- Hypercholesterolemia
- Dyslipidaemia

## Interventions

- **DRUG:** Rosuvastatin
- **DRUG:** Atorvastatin

## Key facts

- **NCT ID:** NCT00653965
- **Lead sponsor:** AstraZeneca
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2003-05
- **Primary completion:** —
- **Final completion:** 2005-02
- **Target enrollment:** 3000 (ESTIMATED)
- **Last updated:** 2009-03-16


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00653965

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00653965, "Treatment of Hypercholesterolaemia in Hispanic Subjects (STARSHIP)". Retrieved via AI Analytics 2026-06-12 from https://api.ai-analytics.org/clinical/NCT00653965. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*